These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10654623)

  • 1. A model that reproduces syndromes associated with human multiple myeloma in nonirradiated SCID mice.
    Barton BE; Cullison J; Jackson J; Murphy T
    Proc Soc Exp Biol Med; 2000 Feb; 223(2):190-7. PubMed ID: 10654623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an in vivo model of human multiple myeloma bone disease.
    Alsina M; Boyce B; Devlin RD; Anderson JL; Craig F; Mundy GR; Roodman GD
    Blood; 1996 Feb; 87(4):1495-501. PubMed ID: 8608240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
    Tassone P; Neri P; Burger R; Savino R; Shammas M; Catley L; Podar K; Chauhan D; Masciari S; Gozzini A; Tagliaferri P; Venuta S; Munshi NC; Anderson KC
    Clin Cancer Res; 2005 Jun; 11(11):4251-8. PubMed ID: 15930364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New xenograft model of multiple myeloma and efficacy of a humanized antibody against human interleukin-6 receptor.
    Tsunenari T; Koishihara Y; Nakamura A; Moriya M; Ohkawa H; Goto H; Shimazaki C; Nakagawa M; Ohsugi Y; Kishimoto T; Akamatsu K
    Blood; 1997 Sep; 90(6):2437-44. PubMed ID: 9310495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive expression of IL-6-LIKE cytokines in normal bone marrow: implications for pathophysiology of myeloma.
    Barton BE; Murphy TF
    Cytokine; 2000 Oct; 12(10):1537-45. PubMed ID: 11023670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonirradiated NOD/SCID-human chimeric animal model for primary human multiple myeloma: a potential in vivo culture system.
    Huang SY; Tien HF; Su FH; Hsu SM
    Am J Pathol; 2004 Feb; 164(2):747-56. PubMed ID: 14742278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinically relevant SCID-hu in vivo model of human multiple myeloma.
    Tassone P; Neri P; Carrasco DR; Burger R; Goldmacher VS; Fram R; Munshi V; Shammas MA; Catley L; Jacob GS; Venuta S; Anderson KC; Munshi NC
    Blood; 2005 Jul; 106(2):713-6. PubMed ID: 15817674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of animal models in multiple myeloma.
    Libouban H
    Morphologie; 2015 Jun; 99(325):63-72. PubMed ID: 25898798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Growth characteristics of a human myeloma cell line transfected with IL-6 cDNA].
    Takahashi T; Okuno Y; Ohsugi Y
    Rinsho Ketsueki; 1993 Apr; 34(4):423-6. PubMed ID: 8510328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-18 inhibits lodging and subsequent growth of human multiple myeloma cells in the bone marrow.
    Yamashita K; Iwasaki T; Tsujimura T; Sugihara A; Yamada N; Ueda H; Okamura H; Futani H; Maruo S; Terada N
    Oncol Rep; 2002; 9(6):1237-44. PubMed ID: 12375027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of a new model of human multiple myeloma using NOD/SCID/gammac(null) (NOG) mice.
    Miyakawa Y; Ohnishi Y; Tomisawa M; Monnai M; Kohmura K; Ueyama Y; Ito M; Ikeda Y; Kizaki M; Nakamura M
    Biochem Biophys Res Commun; 2004 Jan; 313(2):258-62. PubMed ID: 14684154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The proliferative potential of myeloma plasma cells manifest in the SCID-hu host.
    Yaccoby S; Epstein J
    Blood; 1999 Nov; 94(10):3576-82. PubMed ID: 10552969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in vivo model of human multiple myeloma bone disease.
    Alsina M; Boyce BF; Mundy GR; Roodman GD
    Stem Cells; 1995 Aug; 13 Suppl 2():48-50. PubMed ID: 8520511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated growth of a human multiple myeloma cell line in mice with severe combined immunodeficiency disease.
    Huang YW; Richardson JA; Tong AW; Zhang BQ; Stone MJ; Vitetta ES
    Cancer Res; 1993 Mar; 53(6):1392-6. PubMed ID: 8443818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cytokines in cancer cachexia in a murine model of intracerebral injection of human tumours.
    Negri DR; Mezzanzanica D; Sacco S; Gadina M; Benigni F; Cajola L; Finocchiaro G; Ghezzi P; Canevari S
    Cytokine; 2001 Jul; 15(1):27-38. PubMed ID: 11509006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engraftment of human myelodysplastic syndrome derived cell line in transgenic severe combined immunodeficient (TG-SCID) mice expressing human GM-CSF and IL-3.
    Kim DK; Kojima M; Fukushima T; Miyasaka M; Nakauchi H
    Eur J Haematol; 1998 Aug; 61(2):93-9. PubMed ID: 9714520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanisms of multiple myeloma cell growth].
    Simizu S; Konda S
    Rinsho Ketsueki; 1993 Apr; 34(4):418-22. PubMed ID: 8510327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic trioxide is effective in the treatment of multiple myeloma in SCID mice.
    Rousselot P; Larghero J; Labaume S; Poupon J; Chopin M; Dosquet C; Marolleau JP; Janin A; Brouet JC; Fermand JP
    Eur J Haematol; 2004 Mar; 72(3):166-71. PubMed ID: 14962234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ibandronate decreases bone disease development and osteoclast stimulatory activity in an in vivo model of human myeloma.
    Cruz JC; Alsina M; Craig F; Yoneda T; Anderson JL; Dallas M; Roodman GD
    Exp Hematol; 2001 Apr; 29(4):441-7. PubMed ID: 11301184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NOD/SCID-GAMMA mice are an ideal strain to assess the efficacy of therapeutic agents used in the treatment of myeloma bone disease.
    Lawson MA; Paton-Hough JM; Evans HR; Walker RE; Harris W; Ratnabalan D; Snowden JA; Chantry AD
    PLoS One; 2015; 10(3):e0119546. PubMed ID: 25768011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.